Evidence map›Paper›PMID 38434601›Full record

ArticleJAAD case reports2024

Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm.

Viviana Barrera-Penagos, Daniela Castellanos-Leguizamón, José Antonio Hakim-Tawil, Juan José Santivañez, Paula A Rodríguez-Urrego, Juan Carlos Hiromi López-Takegami

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Viviana Barrera-PenagosDepartment of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
Daniela Castellanos-LeguizamónDepartment of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
José Antonio Hakim-TawilDivision of Head and Neck Surgery, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
Juan José SantivañezDivision of Head and Neck Surgery, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
Paula A Rodríguez-UrregoDepartment of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
Juan Carlos Hiromi López-TakegamiDepartment of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
Fundación Santa Fe de Bogotá · COUniversidad de Los Andes · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

basal cell carcinomacollision tumorJanus kinase inhibitorsMerkel cell carcinomaruxolitinibsquamous cell carcinomasynchronous tumor

Identifiers

PMID38434601
PMCPMC10907503
OpenAlexW4391469234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.